The UK Government has advised suppliers of medical products to ensure a six week stock of such products on UK soil on the expiry of the transition period on 31 December.

In new guidance to suppliers, it made clear avoiding disruption to medicines supplies was a priority after the UK leaves the EU customs union and Single Market. Companies are encouraged to review their own logistics arrangements and consider making plans for avoiding the short straits crossing as a priority. It said it will seek information from suppliers to understand their general needs and help identify those who may need more support, for example, with controlled drugs and cold-chain logistics.

The UK Government is not expected at this time to procure extra warehouse capacity to house extra stocks of medical supplies. 

Further guidance in relation to NI is expected in the near future.

Read the UK Government guidance in full here: